• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-Jun 诱导乳腺上皮细胞浸润和乳腺癌干细胞扩增。

c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.

机构信息

Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

出版信息

J Biol Chem. 2010 Mar 12;285(11):8218-26. doi: 10.1074/jbc.M110.100792. Epub 2010 Jan 6.

DOI:10.1074/jbc.M110.100792
PMID:20053993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2832973/
Abstract

The molecular mechanisms governing breast tumor cellular self-renewal contribute to breast cancer progression and therapeutic resistance. The ErbB2 oncogene is overexpressed in approximately 30% of human breast cancers. c-Jun, the first cellular proto-oncogene, is overexpressed in human breast cancer. However, the role of endogenous c-Jun in mammary tumor progression is unknown. Herein, transgenic mice expressing the mammary gland-targeted ErbB2 oncogene were crossed with c-jun(f/f) transgenic mice to determine the role of endogenous c-Jun in mammary tumor invasion and stem cell function. The excision of c-jun by Cre recombinase reduced cellular migration, invasion, and mammosphere formation of ErbB2-induced mammary tumors. Proteomic analysis identified a subset of secreted proteins (stem cell factor (SCF) and CCL5) induced by ErbB2 expression that were dependent upon endogenous c-Jun expression. SCF and CCL5 were identified as transcriptionally induced by c-Jun. CCL5 rescued the c-Jun-deficient breast tumor cellular invasion phenotype. SCF rescued the c-Jun-deficient mammosphere production. Endogenous c-Jun thus contributes to ErbB2-induced mammary tumor cell invasion and self-renewal.

摘要

调控乳腺肿瘤细胞自我更新的分子机制促进了乳腺癌的进展和治疗耐药性。ErbB2 癌基因在大约 30%的人类乳腺癌中过表达。c-Jun 是第一个细胞原癌基因,在人类乳腺癌中过表达。然而,内源性 c-Jun 在乳腺肿瘤进展中的作用尚不清楚。在此,我们将乳腺组织特异性表达 ErbB2 癌基因的转基因小鼠与 c-jun(f/f) 转基因小鼠杂交,以确定内源性 c-Jun 在乳腺肿瘤侵袭和干细胞功能中的作用。Cre 重组酶的切除减少了 ErbB2 诱导的乳腺肿瘤的细胞迁移、侵袭和类器官形成。蛋白质组学分析鉴定出一组由 ErbB2 表达诱导的分泌蛋白(干细胞因子 (SCF) 和 CCL5),这些蛋白依赖于内源性 c-Jun 的表达。SCF 和 CCL5 被鉴定为 c-Jun 转录诱导。CCL5 挽救了 c-Jun 缺陷型乳腺肿瘤细胞侵袭表型。SCF 挽救了 c-Jun 缺陷型乳腺肿瘤细胞类器官生成。因此,内源性 c-Jun 有助于 ErbB2 诱导的乳腺肿瘤细胞侵袭和自我更新。

相似文献

1
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.c-Jun 诱导乳腺上皮细胞浸润和乳腺癌干细胞扩增。
J Biol Chem. 2010 Mar 12;285(11):8218-26. doi: 10.1074/jbc.M110.100792. Epub 2010 Jan 6.
2
Somatic excision demonstrates that c-Jun induces cellular migration and invasion through induction of stem cell factor.体细胞切除表明,c-Jun通过诱导干细胞因子来诱导细胞迁移和侵袭。
Mol Cell Biol. 2007 Feb;27(4):1356-69. doi: 10.1128/MCB.01061-06. Epub 2006 Dec 4.
3
A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.乳腺癌中 c-Jun 信号介导的 BEX2 和 ErbB2 之间的反馈环。
Int J Cancer. 2012 Jan 1;130(1):71-82. doi: 10.1002/ijc.25977. Epub 2011 Apr 20.
4
Targeting the activator protein 1 transcription factor for the prevention of estrogen receptor-negative mammary tumors.靶向激活蛋白1转录因子预防雌激素受体阴性乳腺肿瘤。
Cancer Prev Res (Phila). 2008 Jun;1(1):45-55. doi: 10.1158/1940-6207.CAPR-08-0034. Epub 2008 Mar 31.
5
Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.erbB3表达增加促进erbB2/neu驱动的乳腺肿瘤增殖,同时靶向erbB2/erbB3受体对乳腺癌细胞具有强大的抑制作用。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6143-56. eCollection 2015.
6
A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.一种含有 LPP 和 α-actinin 的复合物,介导了 ErbB2 表达的乳腺癌细胞中 TGFβ 诱导的迁移和侵袭。
J Cell Sci. 2013 May 1;126(Pt 9):1981-91. doi: 10.1242/jcs.118315. Epub 2013 Feb 27.
7
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.ErbB2ΔEx16剪接变体是乳腺癌中的一种主要致癌驱动因子,可促进促转移肿瘤微环境的形成。
Oncogene. 2016 Nov 24;35(47):6053-6064. doi: 10.1038/onc.2016.129. Epub 2016 May 9.
8
Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.在由ErbB2/Neu驱动的肿瘤中,骨膜蛋白/成骨细胞特异性因子-2(periostin/OSF-2)的缺失会导致具有雄激素受体阳性且Notch1活性降低的分子顶泌汗腺样肿瘤。
Breast Cancer Res. 2015 Jan 16;17(1):7. doi: 10.1186/s13058-014-0513-8.
9
The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.葡萄糖转运蛋白GLUT1是ErbB2诱导的乳腺肿瘤发生所必需的。
Breast Cancer Res. 2016 Dec 20;18(1):131. doi: 10.1186/s13058-016-0795-0.
10
Co-opted integrin signaling in ErbB2-induced mammary tumor progression.在ErbB2诱导的乳腺肿瘤进展中被利用的整合素信号传导。
Cancer Cell. 2006 Aug;10(2):93-5. doi: 10.1016/j.ccr.2006.07.015.

引用本文的文献

1
PKC- Regulates an Oncogenic Positive Feedback Loop Between the MAPK/JNK Signaling Pathway, c-Jun/AP-1 and TNF- in Breast Cancer.蛋白激酶C(PKC)调节乳腺癌中丝裂原活化蛋白激酶/应激活化蛋白激酶(MAPK/JNK)信号通路、c-Jun/活化蛋白-1(AP-1)和肿瘤坏死因子(TNF)之间的致癌正反馈环。
Int J Mol Sci. 2025 Jul 28;26(15):7288. doi: 10.3390/ijms26157288.
2
PPARγ acetylation governs mammary adenocarcinoma tumor growth via acetylated residues that determine DNA sequence-specific binding.过氧化物酶体增殖物激活受体γ(PPARγ)乙酰化通过决定DNA序列特异性结合的乙酰化残基来调控乳腺腺癌肿瘤生长。
Oncogene. 2025 Sep;44(37):3476-3492. doi: 10.1038/s41388-025-03492-z. Epub 2025 Jul 26.
3
Network toxicology and molecular docking reveal the potential link between acrylamide exposure and breast cancer.网络毒理学和分子对接揭示了丙烯酰胺暴露与乳腺癌之间的潜在联系。
Sci Rep. 2025 Jul 1;15(1):21076. doi: 10.1038/s41598-025-06964-0.
4
Targeting WEE1 Kinase for Breast Cancer Therapeutics: An Update.靶向WEE1激酶用于乳腺癌治疗:最新进展
Int J Mol Sci. 2025 Jun 13;26(12):5701. doi: 10.3390/ijms26125701.
5
MAPK15 Prevents Expression by Suppressing Oxidative Stress-Dependent Activation of the JNK-JUN Pathway.丝裂原活化蛋白激酶15通过抑制JNK-JUN途径的氧化应激依赖性激活来阻止表达。
Int J Mol Sci. 2025 May 27;26(11):5148. doi: 10.3390/ijms26115148.
6
Apoptotic and anti-migratory activity of rind essential oil encapsulated in niosome against human breast cancer cells.脂质体包裹的果皮精油对人乳腺癌细胞的凋亡和抗迁移活性
Avicenna J Phytomed. 2024 Nov-Dec;14(6):749-763. doi: 10.22038/AJP.2024.24656.
7
Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties.miR-10b 抑制通过靶向干性样特性治疗转移性乳腺癌。
Oncotarget. 2024 Aug 26;15:591-606. doi: 10.18632/oncotarget.28641.
8
Prioritizing drug targets by perturbing biological network response functions.通过干扰生物网络响应功能来优先考虑药物靶点。
PLoS Comput Biol. 2024 Jun 27;20(6):e1012195. doi: 10.1371/journal.pcbi.1012195. eCollection 2024 Jun.
9
Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients.与干性相关的长链非编码 RNA 标志物用于预测 ccRCC 患者的预后和肿瘤免疫微环境。
BMC Med Genomics. 2024 May 31;17(1):150. doi: 10.1186/s12920-024-01920-9.
10
Altering the Cleaving Effector in Chimeric Molecules that Target RNA Enhances Cellular Selectivity.改变靶向 RNA 的嵌合分子中的切割效应子可提高细胞选择性。
ACS Chem Biol. 2023 Nov 17;18(11):2385-2393. doi: 10.1021/acschembio.3c00363. Epub 2023 Oct 12.

本文引用的文献

1
ErbB2 induces Notch1 activity and function in breast cancer cells.erbB2 诱导乳腺癌细胞中的 Notch1 活性和功能。
Clin Transl Sci. 2008 Sep;1(2):107-15. doi: 10.1111/j.1752-8062.2008.00041.x.
2
Cancer stem cells and the cell cycle: targeting the drive behind breast cancer.癌症干细胞与细胞周期:靶向乳腺癌背后的驱动因素
Expert Rev Anticancer Ther. 2009 Mar;9(3):275-9. doi: 10.1586/14737140.9.3.275.
3
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.乳腺癌细胞系包含具有转移能力和独特分子特征的功能性癌症干细胞。
Cancer Res. 2009 Feb 15;69(4):1302-13. doi: 10.1158/0008-5472.CAN-08-2741. Epub 2009 Feb 3.
4
Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice.Sca-1可识别BALB-neuT转基因小鼠乳腺肿瘤中的肿瘤起始细胞。
Neoplasia. 2008 Dec;10(12):1433-43. doi: 10.1593/neo.08902.
5
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.醛脱氢酶1(ALDH1)是正常和恶性人乳腺干细胞的标志物,也是临床预后不良的预测指标。
Cell Stem Cell. 2007 Nov;1(5):555-67. doi: 10.1016/j.stem.2007.08.014.
6
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.携带乳腺癌1号基因(Brca1)的乳腺肿瘤含有具有癌症干细胞特征的不同的CD44+/CD24-细胞和CD133+细胞。
Breast Cancer Res. 2008;10(1):R10. doi: 10.1186/bcr1855. Epub 2008 Feb 1.
7
Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase.c-Jun的破坏通过抑制c-Src和ROCK II激酶的过度激活来减少细胞迁移和侵袭。
Mol Biol Cell. 2008 Apr;19(4):1378-90. doi: 10.1091/mbc.e07-08-0753. Epub 2008 Jan 23.
8
Breast cancer: origins and evolution.乳腺癌:起源与演变
J Clin Invest. 2007 Nov;117(11):3155-63. doi: 10.1172/JCI33295.
9
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.肿瘤基质中的间充质干细胞促进乳腺癌转移。
Nature. 2007 Oct 4;449(7162):557-63. doi: 10.1038/nature06188.
10
A cytokine-mediated link between innate immunity, inflammation, and cancer.先天性免疫、炎症和癌症之间由细胞因子介导的联系。
J Clin Invest. 2007 May;117(5):1175-83. doi: 10.1172/JCI31537.